Lv62
2550 积分 2023-02-28 加入
Do it
Monogenic disorders of the TNF signalling pathway
4天前
已完结
SERENE ER Analysis Part 2 SERENE‐UC: Exposure‐response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis
8天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
8天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
12天前
已完结
Cytokine multimerization: when more is more and sometimes less
13天前
已完结
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
29天前
已完结
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
1个月前
已完结
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
1个月前
已完结
The global burden of inflammatory bowel disease: from 2025 to 2045
1个月前
已完结
Potential of pharmacogenetics in treatment of chronic inflammatory diseases – a danish report overview from 2000 – 2024
1个月前
已完结
皖公网安备34019202002308
